NEWS
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Taysha Gene Therapies (Nasdaq: TSHA) has announced a public offering of up to $75 million in common stock and pre-funded warrants. This offering allows certain investors the option to purchase pre-funded warrants instead of common stock. Additionally, underwriters Jefferies, Goldman Sachs, and Cantor have a 30-day option to buy up to 15% more shares under the same terms. The offering is dependent on market conditions, and there is no guarantee of its completion or terms. A previously filed and approved shelf registration statement with the SEC covers the securities. The offering will proceed via a prospectus and prospectus supplement filed with the SEC. Copies of these documents are available from Jefferies or Goldman Sachs.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1233Followers
76Following
8685Visitors
Follow